RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies

By Gao Lin-Bo  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 827-835

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis

By Zhou Guo-Wu  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 529-535

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects

By Wang Zhanwei   Dong Hairong   Fu Yuanyuan   Ding Haixia  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 765-769

Springer Publishing Company

Access to resources Recommend Favorite

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer

By Gierach Gretchen   Loud Jennifer  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients

By Tilanus-Linthorst Madeleine   Bartels Karina   Alves Celina   Bakri Bonnie   Crepin Ellen   Ouweland Ans   Klijn Jan   Meijers-Heijboer Hanne   Brekelmans Cecile  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite